Is T-Minic banned in India?

T-Minic is a children's cold product combining chlorpheniramine maleate, an antihistamine, with phenylephrine, a decongestant. It is not banned, but its use in the youngest children has been restricted by two notifications.

The concern is old. Decongestant-antihistamine combinations have little evidence of benefit in small children and carry a risk of serious adverse effects, and regulators in several countries advise against them under four or six years. In December 2023 the CDSCO wrote to manufacturers, and on 15 April 2025 the Health Ministry issued S.O. 1717(E) under Section 26A, requiring chlorpheniramine + phenylephrine drops and syrups to carry the statement that the product "shall not be used in children below four years" and not to be promoted for that age. On 18 August 2026, S.O. 4595(E) extended the same condition to every chlorpheniramine + phenylephrine FDC, whatever the dosage form.

T-Minic Oral Drops were historically marketed for infants, which is why the restriction matters most for this brand. Under the 2025 order that use is no longer allowed. T-Minic syrup for older children and the tablet forms continue.

On 19 September 2026 the DGHS placed before the Drugs Consultative Committee a proposal for a red "not below four years" warning on all cough syrups; if adopted it would add a visible label rather than change the legal position. For any child under four with a cold, a doctor can suggest saline drops and paracetamol rather than a combination product.